Israel Englander Design Therapeutics, Inc. Call Options Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023
SELL
$5.5 - $9.77 $195,800 - $347,812
-35,600 Reduced 50.64%
34,700 $200,000
Q4 2022

Feb 14, 2023
BUY
$7.86 - $17.2 $238,158 - $521,160
30,300 Added 75.75%
70,300 $721,000
Q3 2022

Nov 14, 2022
BUY
$14.09 - $25.57 $563,600 - $1.02 Million
40,000 New
40,000 $669,000

Others Institutions Holding DSGN

# of Institutions
101
Shares Held
31.5M
Call Options Held
1.1K
Put Options Held
21.3K
View Full List

About Design Therapeutics, Inc.

DSGN Quotes by TradingView
  • Ticker DSGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,807,900
  • Market Cap $331M
  • Description
  • Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...
More about DSGN
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email